Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Infectious Disease Clinics of North America|September 26, 2001
Infections in patients with end-stage renal disease. An overviewS J BermanHawaii Medical Journal|March 22, 2001
Out-patient parenteral antibiotic therapy (OPAT): clinical outcomes and adverse eventsS J Berman, E W JohnsonJournal of Public Health Management and Practice : JPHMP|October 28, 1999
Extended degree and continuing education preferences of California public health professionalsS J Berman, T E NovotnyBulletin of the World Health Organization|January 1, 1976
Hyperendemic subperiodic Bancroftian filariasis: a search for clinical and immunological correlates of microfilaraemiaR S Desowitz, S J Berman, T PulokaAmerican Journal of Preventive Medicine|January 1, 1995
A continuing education preference survey of public health graduatesS J Berman, V A Perkocha, T E NovotnyJournal of Clinical Microbiology|March 1, 1979
Laboratory evaluation of amikacin susceptibility testing by the AutoBac I systemW H Boughton, S J Berman, M T BoughtonCritical Care Medicine|October 23, 1997
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection GroupB Sieger, S J Berman, R W Geckler, et al.Journal of Chemotherapy (Florence, Italy)|August 31, 2004
Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trialS J Berman, C M Fogarty, T Fabian, et al.Antimicrobial Agents and Chemotherapy|January 1, 1978
Hemodialysis-associated infections: treatment with cephapirinS J Berman, W H Boughton, J G Sugihara, et al.Antimicrobial Agents and Chemotherapy|April 1, 1984
Ceftriaxone pharmacokinetics in patients with various degrees of renal impairmentI H Patel, J G Sugihara, R E Weinfeld, et al.Pageof 2